Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, sulfur burps are a recognized gastrointestinal side effect of Ozempic and other GLP-1 receptor agonists, occurring in a subset of patients during the initial treatment phases. These burps result from slowed gastric emptying, which allows food to remain longer in the stomach and ferment, producing sulfur-containing gases.

For patients considering GLP-1 therapy—whether branded medications or compounded alternatives—understanding the full spectrum of potential GLP-1 effects is essential for informed decision-making. PlexusDx supports this conversation by combining clinical evidence with genetic insights into peptide pathway sensitivity, helping you and your provider anticipate individual response patterns.

How GLP-1 Medications Trigger Sulfur Burps

GLP-1 receptor agonists work by slowing gastric emptying—the rate at which food moves from the stomach into the small intestine. This slower transit allows undigested food and carbohydrates to ferment longer in the stomach, producing hydrogen sulfide and other volatile compounds that escape as sulfur-smelling burps or flatulence.

Delayed gastric emptying also shifts the composition of gut bacteria, favoring fermentation-prone species that generate sulfur compounds. This effect is dose-dependent; higher doses typically cause more pronounced gastrointestinal symptoms. Most patients report sulfur burps peak within 2–4 weeks of starting therapy, then gradually diminish as the body adapts.

Timeline and Prevalence of GLP-1 Gastrointestinal Side Effects

Gastrointestinal side effects from GLP-1 therapy are common but often temporary. Understanding the expected timeline and frequency helps distinguish normal adjustment from medication intolerance. Below is a clinical framework of gastrointestinal effects reported across GLP-1 clinical trials and real-world use.

Side Effect Prevalence Range Typical Timeline Severity Pattern
Sulfur burps / rotten egg odor 15–28% of patients Weeks 1–6, often improves by week 8 Mild to moderate; usually self-limiting
Nausea 40–50% of patients Peaks weeks 1–4; resolves in 60–80% by week 12 Mild to moderate; dose-dependent
Constipation 20–30% of patients Can persist beyond 12 weeks; requires intervention Mild to severe; persistent management needed
Abdominal cramping 10–20% of patients Weeks 1–3; typically resolves by week 6 Mild to moderate; often diet-responsive
Diarrhea 15–22% of patients Variable onset; may emerge weeks 4–12 Mild to moderate; dietary adjustment helps

Why Individual Responses to GLP-1 Vary: Genetic and Biomarker Context

Not all patients experience sulfur burps or gastrointestinal side effects at the same intensity. Genetic variations in GLP-1 receptor sensitivity, glucose metabolism, and gut microbiome composition influence how aggressively the GLP-1 pathway responds, and therefore how pronounced initial gastrointestinal effects are.

PlexusDx's Precision Peptide Genetic Test examines key variants—including GLP1R rs6923761 and other pathway markers—that may help provide context for individual peptide pathway predispositions. Understanding whether you carry variants associated with heightened GLP-1 sensitivity can support a more informed conversation with your provider about dosing strategies, side effect management, and whether compounded or alternative GLP-1 options might suit your profile better.

Managing Sulfur Burps and Optimizing GLP-1 Tolerability

Practical strategies can reduce sulfur burps and other gastrointestinal discomfort. These include eating smaller, frequent meals; avoiding high-fat and heavily processed foods that ferment; staying well-hydrated; and increasing soluble fiber gradually to support healthy gut bacteria. Ginger, peppermint tea, and digestive enzymes may offer additional relief for some patients.

Dose timing matters too. Taking GLP-1 injections in the evening and eating a light dinner can minimize overnight fermentation. If sulfur burps persist beyond 6–8 weeks or significantly impact quality of life, discuss with your provider whether dose adjustment, medication type adjustment (for example, from injection to oral form), or temporary dose pausing is appropriate. PlexusDx compounded options offer flexibility in dosing commitment tiers—month-to-month, 3-month, and 6-month plans—allowing you to adjust your treatment pace without financial penalty as your tolerance evolves.

How PlexusDx Supports a More Personalized Approach

PlexusDx genetic insights may help provide context for your individual GLP-1 sensitivity profile before you start treatment. By understanding whether your genetic predispositions suggest higher or lower GLP-1 pathway activation, you and your provider can proactively plan dosing strategies and side effect mitigation—potentially reducing the intensity of early gastrointestinal symptoms like sulfur burps.

The Precision Peptide Genetic Test reveals predispositions in key peptide pathway variants (GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, MC4R rs17782313) that may influence how your body responds to GLP-1 activation. These results should be interpreted with a qualified healthcare provider—they help contextualize expected response patterns but do not predict exact medication response or guarantee freedom from side effects.

Using genetic predisposition data alongside clinical evidence supports a more personalized conversation with your provider about which GLP-1 formulation (injection or oral) and dosing commitment might align best with your tolerance profile and lifestyle. This informed approach is central to PlexusDx's precision-wellness model.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves